DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Otros (Other)
Siglec-1 on dendritic cells mediates SARS-CoV-2 trans-infection of target cells while on macrophages triggers proinflammatory responses
COVID-19 pandemic is not yet under control by vaccination, and effective antivirals are critical for preparedness. Here we report that macrophages and dendritic cells, key antigen presenting myeloid cells (APCs), are largely resistant to SARS-CoV-2 infection. APCs effectively captured viruses within cellular compartments that lead to antigen degradation. Macrophages sense SARS-CoV-2 and released higher levels of cytokines, including those related to cytokine storm in severe COVID-19. The sialic acid-binding Ig-like lectin 1 (Siglec-1/CD169) present on APCs, which interacts with sialylated gangliosides on membranes of retroviruses or filoviruses, also binds SARS-CoV-2 via GM1. Blockage of Siglec-1 receptors by monoclonal antibodies reduces SARS-CoV-2 uptake and transfer to susceptible target cells. APCs expressing Siglec-1 and carrying SARS-CoV-2 are found in pulmonary tissues of non-human primates. Single cell analysis reveals the in vivo induction of cytokines in those macrophages. Targeting Siglec-1 could offer cross-protection against SARS-CoV-2 and other enveloped viruses that exploit APCs for viral dissemination, including those yet to come in future outbreaks., The research of CBIG consortium (constituted by IRTA-CReSA, BSC, & IrsiCaixa) is
supported by Grifols pharmaceutical. The authors also acknowledge the crowdfunding
initiative #Yomecorono (https://www.yomecorono.com). J.M-P. is supported by grant
PID2019-109870RB-I00 from the Spanish Ministry of Science and Innovation and in
part also by Grifols. CR lab is funded by RTI2018-094445-B100 (MCIU/AEI/FEDER,
UE). The authors also acknowledge the crowdfunding initiative #Yomecorono
(https://www.yomecorono.com). The NHP study was primarily supported by YNPRC
Coronavirus Pilot Research Project Program grant to M.Pa. under award P51 OD11132,
Emergent Venture Fast grant program to MPa under awards #2206 and #2144, and
William and Lula Pitts Foundation (to MPa)., No